Global Precision Diagnostics & Medicine Market Size Study & Forecast by Type (Genetic Tests, Esoteric Tests, and Others) and Application (Oncology, Cardiovascular, Neurology, and Others) and Regional Forecasts 2022-2032

Description

The Global Precision Diagnostics & Medicine Market, valued at approximately USD 75.85 billion in 2024, is poised to surge with a compound annual growth rate (CAGR) of 13.10% from 2025 through 2035. Precision diagnostics and medicine encompass a transformative approach within healthcare that leverages advanced testing techniques-ranging from genetic to esoteric tests-to tailor therapeutic interventions precisely to patient profiles. This evolution facilitates early detection, personalized treatment plans, and improved patient outcomes, thereby driving the momentum of the market. The growing prevalence of chronic diseases, rapid advancements in molecular diagnostics, and increased healthcare expenditure across developed and emerging economies collectively bolster market expansion.

This escalating demand for precision diagnostics is closely tied to breakthroughs in genomic sequencing and biomarker identification, which enable clinicians to pinpoint disease etiologies with unprecedented accuracy. Oncology remains the foremost application segment, as the integration of precision medicine significantly refines cancer diagnosis and treatment paradigms. Meanwhile, cardiovascular and neurological disorders also present robust avenues for growth, propelled by increasing incidence rates and the urgent need for personalized healthcare solutions. Furthermore, expanding end-user adoption-spanning hospitals, clinical laboratories, and emerging homecare diagnostic platforms-reflects an evolving landscape where accessibility and patient-centric care remain paramount. Nevertheless, challenges such as regulatory complexities and high costs may temper market acceleration during the forecast horizon.

Regionally, North America dominates the precision diagnostics and medicine arena, buoyed by its sophisticated healthcare infrastructure, substantial R&D investments, and a strong presence of key market players. The United States, in particular, leads in adopting cutting-edge diagnostic technologies and personalized therapies, supported by favorable reimbursement policies and robust regulatory frameworks. Europe follows closely, driven by rising healthcare awareness and governmental support across countries like Germany, the UK, and France. However, Asia Pacific is anticipated to witness the fastest growth, fueled by burgeoning healthcare infrastructure, rising disposable incomes, and increasing disease burden in populous countries such as China and India. Additionally, strategic collaborations and government initiatives aimed at advancing precision medicine are catalyzing market expansion in this region. Latin America and the Middle East & Africa, although comparatively nascent, are progressively investing in precision healthcare capabilities, offering promising prospects for future growth.

Major market players included in this report are:

Bayer AG
Thermo Fisher Scientific Inc.
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Agilent Technologies, Inc.
Becton, Dickinson and Company
Siemens Healthineers AG
PerkinElmer, Inc.
QIAGEN N.V.
Charles River Laboratories International, Inc.
Exact Sciences Corporation
Invitae Corporation
Guardant Health, Inc.
BD Diagnostics

Global Precision Diagnostics & Medicine Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast Period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Type:

Genetic Tests
Esoteric Tests
Others

By Application:

Oncology
Cardiovascular
Neurology
Others

By End User:

Hospitals
Clinical Laboratories
Homecare

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe (ROE)
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific (RoAPAC)
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Precision Diagnostics & Medicine Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Precision Diagnostics & Medicine Market Forces Analysis

3.1. Market Forces Shaping The Global Precision Diagnostics & Medicine Market (2024-2035)
3.2. Drivers
- 3.2.1. Growing Prevalence of Chronic Diseases
- 3.2.2. Advancements in Molecular Diagnostics and Genomic Sequencing
3.3. Restraints
- 3.3.1. Regulatory Complexities and Approvals
- 3.3.2. High Cost of Precision Diagnostic Tests and Therapies
3.4. Opportunities
- 3.4.1. Expansion of Homecare Diagnostic Platforms
- 3.4.2. Increasing Healthcare Expenditure in Emerging Economies

Chapter 4. Global Precision Diagnostics & Medicine Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Precision Diagnostics & Medicine Market Size & Forecasts by Type 2025-2035

5.1. Market Overview
5.2. Global Precision Diagnostics & Medicine Market Performance - Potential Analysis (2025)
5.3. Genetic Tests
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market Size Analysis, by Region, 2025-2035
5.4. Esoteric Tests
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market Size Analysis, by Region, 2025-2035
5.5. Others
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market Size Analysis, by Region, 2025-2035

Chapter 6. Global Precision Diagnostics & Medicine Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Precision Diagnostics & Medicine Market Performance - Potential Analysis (2025)
6.3. Oncology
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market Size Analysis, by Region, 2025-2035
6.4. Cardiovascular
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market Size Analysis, by Region, 2025-2035
6.5. Neurology
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market Size Analysis, by Region, 2025-2035
6.6. Others
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market Size Analysis, by Region, 2025-2035

Chapter 7. Global Precision Diagnostics & Medicine Market Size & Forecasts by Region 2025-2035

7.1. Precision Diagnostics & Medicine Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Precision Diagnostics & Medicine Market
- 7.3.1. U.S. Precision Diagnostics & Medicine Market
  - 7.3.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.3.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.3.2. Canada Precision Diagnostics & Medicine Market
  - 7.3.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.3.2.2. Application Breakdown Size & Forecasts, 2025-2035
7.4. Europe Precision Diagnostics & Medicine Market
- 7.4.1. UK Precision Diagnostics & Medicine Market
  - 7.4.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.2. Germany Precision Diagnostics & Medicine Market
  - 7.4.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.3. France Precision Diagnostics & Medicine Market
  - 7.4.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.3.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.4. Spain Precision Diagnostics & Medicine Market
  - 7.4.4.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.4.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.5. Italy Precision Diagnostics & Medicine Market
  - 7.4.5.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.5.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.4.6. Rest of Europe Precision Diagnostics & Medicine Market
  - 7.4.6.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.6.2. Application Breakdown Size & Forecasts, 2025-2035
7.5. Asia Pacific Precision Diagnostics & Medicine Market
- 7.5.1. China Precision Diagnostics & Medicine Market
  - 7.5.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.2. India Precision Diagnostics & Medicine Market
  - 7.5.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.3. Japan Precision Diagnostics & Medicine Market
  - 7.5.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.3.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.4. Australia Precision Diagnostics & Medicine Market
  - 7.5.4.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.4.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.5. South Korea Precision Diagnostics & Medicine Market
  - 7.5.5.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.5.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.5.6. Rest of Asia Pacific Precision Diagnostics & Medicine Market
  - 7.5.6.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.6.2. Application Breakdown Size & Forecasts, 2025-2035
7.6. Latin America Precision Diagnostics & Medicine Market
- 7.6.1. Brazil Precision Diagnostics & Medicine Market
  - 7.6.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.6.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.6.2. Mexico Precision Diagnostics & Medicine Market
  - 7.6.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.6.2.2. Application Breakdown Size & Forecasts, 2025-2035
7.7. Middle East and Africa Precision Diagnostics & Medicine Market
- 7.7.1. UAE Precision Diagnostics & Medicine Market
  - 7.7.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Precision Diagnostics & Medicine Market
  - 7.7.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.7.3. South Africa Precision Diagnostics & Medicine Market
  - 7.7.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.3.2. Application Breakdown Size & Forecasts, 2025-2035
- 7.7.4. Rest of Middle East & Africa Precision Diagnostics & Medicine Market
  - 7.7.4.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.4.2. Application Breakdown Size & Forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Bayer AG
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Thermo Fisher Scientific Inc.
8.4. Illumina, Inc.
8.5. F. Hoffmann-La Roche Ltd.
8.6. Abbott Laboratories
8.7. Agilent Technologies, Inc.
8.8. Becton, Dickinson and Company
8.9. Siemens Healthineers AG
8.10. PerkinElmer, Inc.
8.11. QIAGEN N.V.
8.12. Charles River Laboratories International, Inc.
8.13. Exact Sciences Corporation
8.14. Invitae Corporation
8.15. Guardant Health, Inc.
8.16. BD Diagnostics